Variant report

Variant	esv3436816
Chromosome Location	chr15:41860414-41861193
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:150)
CpG islands
(count:61)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:150 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr15:41860653-41860993	HepG2	liver:	n/a	n/a
2	ATF2	chr15:41860557-41861051	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF2	chr15:41860068-41860472	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF2	chr15:41860472-41861025	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr15:41860865-41861037	H1-hESC	embryonic stem cell:	n/a	n/a
6	BHLHE40	chr15:41860681-41861001	HepG2	liver:	n/a	n/a
7	BHLHE40	chr15:41860663-41860934	K562	blood:	n/a	n/a
8	BRCA1	chr15:41860114-41861134	H1-hESC	embryonic stem cell:	n/a	n/a
9	BRCA1	chr15:41860805-41861195	HepG2	liver:	n/a	n/a
10	CBX3	chr15:41860608-41860940	K562	blood:	n/a	n/a
11	CCNT2	chr15:41860696-41860984	K562	blood:	n/a	chr15:41860802-41860822
12	CEBPB	chr15:41860702-41860964	H1-hESC	embryonic stem cell:	n/a	n/a
13	CEBPB	chr15:41860586-41860934	HepG2	liver:	n/a	n/a
14	CHD1	chr15:41860335-41860894	H1-hESC	embryonic stem cell:	n/a	n/a
15	CHD2	chr15:41860632-41861053	HepG2	liver:	n/a	n/a
16	CHD2	chr15:41860689-41860995	K562	blood:	n/a	n/a
17	CHD2	chr15:41860575-41861075	H1-hESC	embryonic stem cell:	n/a	n/a
18	CTCF	chr15:41860758-41860902	K562	blood:	n/a	n/a
19	CTCF	chr15:41860860-41861010	HRPEpiC	eye:	n/a	chr15:41860894-41860907
20	CTCF	chr15:41860700-41860850	Caco-2	colon:	n/a	n/a
21	CTCF	chr15:41860860-41861010	HCM	heart:	n/a	chr15:41860894-41860907
22	CTCF	chr15:41860860-41861010	HPAF	blood vessel:	n/a	chr15:41860894-41860907
23	CTCF	chr15:41860740-41860890	HepG2	liver:	n/a	n/a
24	CTCF	chr15:41860820-41860970	HepG2	liver:	n/a	chr15:41860894-41860907
25	CTCF	chr15:41860800-41860950	HPAF	blood vessel:	n/a	chr15:41860894-41860907
26	CTCF	chr15:41860820-41860970	Caco-2	colon:	n/a	chr15:41860894-41860907
27	ELF1	chr15:41860627-41861055	HepG2	liver:	n/a	chr15:41860771-41860784
28	ELF1	chr15:41860593-41861001	HepG2	liver:	n/a	chr15:41860771-41860784
29	ELF1	chr15:41860582-41860976	K562	blood:	n/a	chr15:41860771-41860784
30	EP300	chr15:41860650-41861060	H1-hESC	embryonic stem cell:	n/a	n/a
31	EP300	chr15:41860524-41861088	HepG2	liver:	n/a	n/a
32	EP300	chr15:41860570-41860990	K562	blood:	n/a	n/a
33	EP300	chr15:41860486-41861109	HepG2	liver:	n/a	n/a
34	EP300	chr15:41860651-41861103	HepG2	liver:	n/a	n/a
35	EP300	chr15:41860576-41860974	H1-hESC	embryonic stem cell:	n/a	n/a
36	FOSL2	chr15:41860553-41861095	HepG2	liver:	n/a	n/a
37	FOXA1	chr15:41860481-41861156	HepG2	liver:	n/a	n/a
38	FOXA1	chr15:41860499-41861067	HepG2	liver:	n/a	n/a
39	FOXA1	chr15:41860431-41861032	HepG2	liver:	n/a	n/a
40	FOXA1	chr15:41860595-41860966	A549	lung:	n/a	n/a
41	FOXA1	chr15:41860436-41861138	HepG2	liver:	n/a	n/a
42	FOXA2	chr15:41860554-41861071	HepG2	liver:	n/a	n/a
43	FOXA2	chr15:41860642-41861058	A549	lung:	n/a	n/a
44	FOXP2	chr15:41860630-41860966	PFSK-1	brain:	n/a	n/a
45	FOXP2	chr15:41860625-41860997	PFSK-1	brain:	n/a	n/a
46	FOXP2	chr15:41860690-41860930	SK-N-MC	brain:	n/a	n/a
47	GTF2F1	chr15:41859932-41861122	H1-hESC	embryonic stem cell:	n/a	n/a
48	HDAC2	chr15:41860613-41861110	H1-hESC	embryonic stem cell:	n/a	chr15:41860993-41861001 chr15:41860812-41860821
49	HDAC2	chr15:41860586-41861092	HepG2	liver:	n/a	chr15:41860993-41861001 chr15:41860812-41860821
50	HDAC2	chr15:41860493-41861161	HepG2	liver:	n/a	chr15:41860993-41861001 chr15:41860812-41860821

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr15:41860668-41860718	AG09309	skin:	n/a
2	chr15:41860668-41860718	LNCaP	prostate:	n/a
3	chr15:41860668-41860718	GM12891	blood:	n/a
4	chr15:41860668-41860718	ECC-1	luminal epithelium:	n/a
5	chr15:41860668-41860718	H1-hESC	embryonic stem cell:	embryo
6	chr15:41860668-41860718	HCT-116	colon:	n/a
7	chr15:41860668-41860718	PrEC	prostate:	n/a
8	chr15:41860668-41860718	SK-N-MC	brain:	n/a
9	chr15:41860668-41860718	GM12878	blood:	n/a
10	chr15:41860668-41860718	AoSMC	blood vessel:	n/a
11	chr15:41860668-41860718	BJ	skin:	n/a
12	chr15:41860668-41860718	HIPEpiC	eye:	n/a
13	chr15:41860668-41860718	HUVEC	blood vessel:	n/a
14	chr15:41860668-41860718	Jurkat	blood:	n/a
15	chr15:41860668-41860718	SKMC	muscle:	n/a
16	chr15:41860668-41860718	A549	lung:	n/a
17	chr15:41860668-41860718	AG09319	gingival:	n/a
18	chr15:41860668-41860718	HAEpiC	amniotic membrane:	n/a
19	chr15:41860668-41860718	MCF10A-Er-Src	breast:	n/a
20	chr15:41860668-41860718	HepG2	liver:	n/a
21	chr15:41860668-41860718	HEEpiC	esophagus:	n/a
22	chr15:41860668-41860718	GM06990	blood:	n/a
23	chr15:41860668-41860718	Hepatocyte	liver:	n/a
24	chr15:41860668-41860718	MCF-7	breast:	n/a
25	chr15:41860668-41860718	PANC-1	pancreas:	n/a
26	chr15:41860668-41860718	RPTEC	kidney:	n/a
27	chr15:41860668-41860718	HRPEpiC	eye:	n/a
28	chr15:41860668-41860718	AG04450	lung:	fetal
29	chr15:41860668-41860718	NT2-D1	testis:	n/a
30	chr15:41860668-41860718	NB4	blood:	n/a
31	chr15:41860668-41860718	ovcar-3	ovarian:	n/a
32	chr15:41860668-41860718	HL-60	blood:	n/a
33	chr15:41860668-41860718	NHDF-neo	bronchial:	n/a
34	chr15:41860668-41860718	CMK	blood:	n/a
35	chr15:41860668-41860718	HRE	kidney:	n/a
36	chr15:41860668-41860718	NHBE	bronchial:	n/a
37	chr15:41860668-41860718	U87	brain:	n/a
38	chr15:41860668-41860718	GM19239	blood:	n/a
39	chr15:41860668-41860718	HCF	heart:	n/a
40	chr15:41860668-41860718	SK-N-SH	brain:	n/a
41	chr15:41860668-41860718	Hela-S3	cervix:	n/a
42	chr15:41860668-41860718	HEK293	kidney:	embryo
43	chr15:41860668-41860718	AG10803	skin:	n/a
44	chr15:41860668-41860718	ProgFib	skin:	n/a
45	chr15:41860668-41860718	IMR90	lung:	fetal
46	chr15:41860668-41860718	SAEC	small airway:	n/a
47	chr15:41860668-41860718	BE2_C	brain:	n/a
48	chr15:41860668-41860718	HCM	heart:	n/a
49	chr15:41860668-41860718	T-47D	breast:	n/a
50	chr15:41860668-41860718	SK-N-SH_RA	brain:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr15:41849860..41852803-chr15:41858013..41860929,2	MCF-7	breast:

No data

Variant related genes	Relation type
TYRO3	TF binding region
TYRO3	CpG island
ENSG00000092445	chromatin interactions

Extended variants
information (count: 36 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:36 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs149022450	chr15:41860425-41860426	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs375950983	chr15:41860446-41860447	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs140010890	chr15:41860450-41860451	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs142466939	chr15:41860480-41860481	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs12148316	chr15:41860490-41860491	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
6	rs542143718	chr15:41860491-41860492	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs140553891	chr15:41860505-41860506	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs527331118	chr15:41860507-41860508	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs150035019	chr15:41860510-41860511	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs147808646	chr15:41860512-41860513	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs368326516	chr15:41860515-41860516	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs201515583	chr15:41860518-41860519	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs372263785	chr15:41860527-41860528	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs55689932	chr15:41860565-41860566	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs564021298	chr15:41860650-41860651	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Active TSS Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs117053817	chr15:41860668-41860669	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Active TSS Weak transcription Strong transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs2289743	chr15:41860698-41860699	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Active TSS Weak transcription Strong transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
18	rs570262885	chr15:41860727-41860728	Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Active TSS Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs529451134	chr15:41860831-41860832	Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs541765827	chr15:41860841-41860842	Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs549308066	chr15:41860842-41860843	Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs566030910	chr15:41860945-41860946	Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs534939819	chr15:41860965-41860966	Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs557739128	chr15:41860978-41860979	Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs143029967	chr15:41860983-41860984	Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs535113436	chr15:41861013-41861014	Enhancers Weak transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs28704130	chr15:41861040-41861041	Enhancers Weak transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs148272463	chr15:41861059-41861060	Enhancers Weak transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs199641637	chr15:41861126-41861127	Enhancers Weak transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs375597382	chr15:41861142-41861143	Enhancers Weak transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs576219159	chr15:41861145-41861146	Enhancers Weak transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs200610593	chr15:41861146-41861147	Enhancers Weak transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs34587671	chr15:41861153-41861154	Enhancers Weak transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs201575640	chr15:41861154-41861155	Enhancers Weak transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs199712738	chr15:41861163-41861164	Enhancers Weak transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs555742720	chr15:41861167-41861168	Enhancers Weak transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:69)

Disease	PMID	Source
HDAC8	0	CNVD
NIPBL	0	CNVD
RAD21	0	CNVD
SMC1A	0	CNVD
SMC3	0	CNVD
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Angelman syndrome	16183798	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Testicular germ cell tumor	18059402	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Melanoma	18172304	CNVD
Colorectal cancer	16774939	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
Intellectual disability	22102821	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	21785460	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Ovarian cancer	22174824	CNVD
Prostate cancer	18632612	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	17053054	CNVD
Cancer	20164920	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Cancer	21129771	CNVD
Papillary thyroid carcinoma	22161024	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	21045282	CNVD
Breast cancer	22032731	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelofibrosis	22110671	CNVD
Maculopathy	20981449	CNVD
Gastric adenocarcinoma	19115996	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:113 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:41852200-41877400	Weak transcription	Aorta	Aorta
2	chr15:41852400-41860600	Weak transcription	HUVEC	blood vessel
3	chr15:41852400-41877200	Weak transcription	Colon Smooth Muscle	Colon
4	chr15:41852600-41877400	Weak transcription	HMEC	breast
5	chr15:41852800-41877400	Weak transcription	NHEK	skin
6	chr15:41853000-41861800	Genic enhancers	Fetal Intestine Large	intestine
7	chr15:41853000-41862000	Genic enhancers	Fetal Intestine Small	intestine
8	chr15:41853200-41861800	Genic enhancers	Fetal Adrenal Gland	Adrenal Gland
9	chr15:41853200-41863200	Genic enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
10	chr15:41853200-41872600	Weak transcription	Hela-S3	cervix
11	chr15:41853400-41870600	Weak transcription	Stomach Mucosa	stomach
12	chr15:41853600-41862200	Weak transcription	Duodenum Mucosa	Duodenum
13	chr15:41853800-41861400	Genic enhancers	Brain Dorsolateral Prefrontal Cortex	brain
14	chr15:41853800-41864000	Genic enhancers	Brain Cingulate Gyrus	brain
15	chr15:41854000-41860800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
16	chr15:41854000-41871400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
17	chr15:41854200-41877000	Weak transcription	Fetal Brain Male	brain
18	chr15:41855000-41861400	Genic enhancers	Brain Anterior Caudate	brain
19	chr15:41855400-41862000	Weak transcription	NHLF	lung
20	chr15:41855400-41863400	Weak transcription	Muscle Satellite Cultured Cells	--
21	chr15:41855400-41864400	Genic enhancers	Brain Hippocampus Middle	brain
22	chr15:41855400-41877000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
23	chr15:41855400-41877200	Weak transcription	Duodenum Smooth Muscle	Duodenum
24	chr15:41855600-41860600	Weak transcription	NH-A	brain
25	chr15:41856400-41861800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
26	chr15:41856800-41861400	Genic enhancers	Brain Angular Gyrus	brain
27	chr15:41857000-41860800	Weak transcription	Brain Germinal Matrix	brain
28	chr15:41857200-41860800	Weak transcription	HSMMtube	muscle
29	chr15:41857200-41862200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
30	chr15:41857400-41864000	Genic enhancers	Brain Inferior Temporal Lobe	brain
31	chr15:41857600-41863200	Weak transcription	Fetal Brain Female	brain
32	chr15:41858200-41861000	Enhancers	Brain Substantia Nigra	brain
33	chr15:41858200-41861400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
34	chr15:41858600-41861000	Enhancers	A549	lung
35	chr15:41858600-41861400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
36	chr15:41858600-41861400	Enhancers	Fetal Heart	heart
37	chr15:41858800-41861400	Genic enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
38	chr15:41858800-41863200	Genic enhancers	Ovary	ovary
39	chr15:41859000-41865400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
40	chr15:41859000-41866200	Weak transcription	NHDF-Ad	bronchial
41	chr15:41859000-41869000	Strong transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
42	chr15:41859200-41861200	Genic enhancers	Cortex derived primary cultured neurospheres	brain
43	chr15:41859200-41861200	Enhancers	Fetal Kidney	kidney
44	chr15:41859400-41861000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr15:41859600-41860600	Enhancers	Adipose Nuclei	Adipose
46	chr15:41859600-41860800	Genic enhancers	Spleen	Spleen
47	chr15:41859600-41861200	Enhancers	Pancreas	Pancrea
48	chr15:41859600-41861200	Enhancers	Placenta Amnion	Placenta Amnion
49	chr15:41859600-41861400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
50	chr15:41859600-41865800	Strong transcription	Stomach Smooth Muscle	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links